SRSF1 and lung cancer: Consistent with this possibility, Gefitinib-resistant HCC827 lung cancer cells, which had a much faster growth rate as compared to the parental HCC827 cells (Fig. 7a), also displayed elevated expression of SRSF1 (Fig. 7b).